Table 2 Showing the quality of different anti-malarials in different study communities
| Â | Dihydroartemesinin N = 4 n (%) | Quinine N = 28 n (%) | Sulphadoxine-Pyrimethamine (SP) N = 113 n (%) | Chloroquine N = 56 n (%) | Artesunate N = 24 n (%) | Total N = 225 n (%) |
|---|---|---|---|---|---|---|
Pass* | 3 (75) | 15 (54) | 69 (61) | 54 (96) | 24 (100) | 165 (73) |
Fail* | 1 (25) | 13 (46) | 44 (39) | 2 (4) | 0 (0) | 60 (37) |
Total | 4 (100) | 28 (100) | 113(100) | 56 (100) | 24 (100) | 225 (100) |
Failures | Â | Â | Â | Â | Â | Â |
Public | 0 (0) | 2 (15) | 9 (21) | 2 (100) | 0 (0) | 13 (22) |
Private | 1 (100) | 11 (85) | 35 (79) | 0 (0) | 0 (0) | 47 (78) |
Total | 1 (100) | 13 (100) | 44 (100) | 2 (100) | 0 (0) | 60 (100) |
Failures | Â | Â | Â | Â | Â | Â |
Low level | 0 (0) | 10 (77) | 25 (57) | 1 (50) | 0 (0) | 36 (60) |
High/med | 1 (100) | 3 (23) | 19 (43) | 1 (50) | 0 (0) | 24 (40) |
Total | 1 (100) | 13 (100) | 44 (100) | 2 (100) | 0 (0) | 60 (100) |